'Target-and-release' nanoparticles for effective immunotherapy of metastatic ovarian cancer
I. S. Pires, G. Covarrubias, V. F. Gomerdinger, C. M. Backlund, A. Shanker, E. Gordon, S. Wu, A. J. Pickering, M. B. Melo, H. Suh, D. J. Irvine, P. T. Hammond
This study develops IL-12-loaded nanoparticles that enhance immunotherapy for metastatic ovarian cancer by promoting T cell accumulation and sensitizing tumors to checkpoint inhibitors.
bioRxiv · Jul 5, 2024Bioengineering